These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase. Tse R; Vavougios G; Hou Y; Mahuran DJ Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542 [TBL] [Abstract][Full Text] [Related]
5. Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins. Tse R; Wu YJ; Vavougios G; Hou Y; Hinek A; Mahuran DJ Biochemistry; 1996 Aug; 35(33):10894-903. PubMed ID: 8718882 [TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation (C522Y) is present in the beta-hexosaminidase beta-subunit gene of a Japanese patient with infantile Sandhoff disease. Kuroki Y; Itoh K; Nadaoka Y; Tanaka T; Sakuraba H Biochem Biophys Res Commun; 1995 Jul; 212(2):564-71. PubMed ID: 7626071 [TBL] [Abstract][Full Text] [Related]
7. Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb. Yamanaka S; Johnson ON; Norflus F; Boles DJ; Proia RL Genomics; 1994 Jun; 21(3):588-96. PubMed ID: 7959736 [TBL] [Abstract][Full Text] [Related]
9. Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant. Ribeiro MG; Sonin T; Pinto RA; Fontes A; Ribeiro H; Pinto E; Palmeira MM; Sá Miranda MC J Med Genet; 1996 Apr; 33(4):341-3. PubMed ID: 8730294 [TBL] [Abstract][Full Text] [Related]
10. Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene. Navon R; Khosravi R; Melki J; Drucker L; Fontaine B; Turpin JC; N'Guyen B; Fardeau M; Rondot P; Baumann N Ann Neurol; 1997 May; 41(5):631-8. PubMed ID: 9153525 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574 [TBL] [Abstract][Full Text] [Related]
12. GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. Tanaka A; Ohno K; Suzuki K Biochem Biophys Res Commun; 1988 Oct; 156(2):1015-9. PubMed ID: 2973311 [TBL] [Abstract][Full Text] [Related]
13. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease]. Peleg L; Gazit E; Goldman B; Akstein E Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957 [No Abstract] [Full Text] [Related]
14. Identification of plasma membrane associated mature beta-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts. Mencarelli S; Cavalieri C; Magini A; Tancini B; Basso L; Lemansky P; Hasilik A; Li YT; Chigorno V; Orlacchio A; Emiliani C; Sonnino S FEBS Lett; 2005 Oct; 579(25):5501-6. PubMed ID: 16212960 [TBL] [Abstract][Full Text] [Related]
15. Chronic GM2 gangliosidosis type Sandhoff associated with a novel missense HEXB gene mutation causing a double pathogenic effect. Santoro M; Modoni A; Sabatelli M; Madia F; Piemonte F; Tozzi G; Ricci E; Tonali PA; Silvestri G Mol Genet Metab; 2007 May; 91(1):111-4. PubMed ID: 17251047 [TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement in feline GM2 gangliosidosis: catabolic effects of human beta-hexosaminidase A. Rattazzi MC; Appel AM; Baker HJ Prog Clin Biol Res; 1982; 94():213-20. PubMed ID: 6214798 [No Abstract] [Full Text] [Related]
18. Sequencing, expression, and enzymatic characterization of beta-hexosaminidase in rabbit lacrimal gland and primary cultured acinar cells. Andersson SV; Sjögren EC; Magnusson C; Gierow JP Glycobiology; 2005 Mar; 15(3):211-20. PubMed ID: 15483268 [TBL] [Abstract][Full Text] [Related]
19. Three novel beta-hexosaminidase A mutations in obligate carriers of Tay-Sachs disease. Tomczak J; Grebner EE Hum Mutat; 1994; 4(1):71-2. PubMed ID: 7951261 [No Abstract] [Full Text] [Related]
20. Spinal muscular atrophy is not the result of mutations at the beta-hexosaminidase or GM2-activator locus. Kleyn PW; Brzustowicz LM; Wilhelmsen KC; Freimer NB; Miller JM; Munsat TL; Gilliam TC Neurology; 1991 Sep; 41(9):1418-22. PubMed ID: 1679910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]